Latest News

Fighting TB – South Africa’s ‘insidious epidemic’

Posted 02/06/2015

South Africa stands at the centre of a global TB epidemic devastating the health of millions and their communities. Oxford University is working with South African researchers, health workers and community volunteers in the hunt for an urgently-needed new vaccine. Professor Helen McShane, Jenner Investigator, has been working with local and international organisations to build a system of trialling vaccines, with the active participation of the local community.

Vaccinology Career Development Workshop

Posted 03/06/2015

This one day Workshop is being co-hosted by Professor Gary Entrican on 27th October at the Moredun Institute, Edinburgh. It will include a range of presentations focusing on career development in veterinary vaccinology, providing complementary perspectives from funders and successful grant winners. The workshop is designed to educate and provide skills for early career researchers to develop their careers within vaccinology.

Antigen Discovery and Proteomics of Host Response Workshop

Posted 03/06/2015

Antigen Discovery and Proteomics of Host Response workshop, hosted at the University of Liverpool on 18th November 2015.   

The workshop will be hosted at the Foresight Centre and will include a range of presentations focusing on antigen discovery and the proteomics of host response, providing complementary perspectives of both research of the antigen and host response.This workshop is designed to educate researchers in the latest updates on antigen discovery and proteomics of host response as well as the tools and technologies to be able to conduct such research.

New Malaria Vaccine shows promise in field trial

New Malaria Vaccine shows promise in field trial

Posted 08/05/2015

A vaccine against Malaria, developed at the Jenner Institute, has shown promising results in its first field trial. The trial in Kenya found that the vaccine was 67% effective against Plasmodium falciparum infections - see BBC report.

Transmission blocking malaria vaccines

Transmission blocking malaria vaccines

Posted 24/04/2015

This year’s World Health Organisation (WHO) World Malaria Day (on 25th April) has the theme of ‘Defeat Malaria’. Nearly half the world’s population is at risk of contracting the disease, and millions are affected by malaria every year. Dr Sumi Biswas work on developing vaccines that block the blood transmission of malaria has won her a Grand Challenges Explorations Award.

Immunization week 2015: Making Vaccines More Effective

Posted 28/04/2015

24 -30th April each year is the World Health Organisation World Immunization Week. To mark this occasion, NDM spoke to Professor Simon Draper, a MRC Career Development Fellow based at the Jenner Institute, about making vaccines more effective.

Simon Draper: A vaccine relies on the remarkable ability of the immune system to recognise what it has seen before – we call this process immunological memory.

World Immunization Week 2015: Ebola Vaccines

Posted 28/04/2015

The last week of April each year is the World Health Organisation Immunization Week. Clinical trials are an essential part of vaccine development and The Jenner Institute has been involved in a fast-tracked Ebola Phase I clinical trial in response to the Ebola outbreak in West Africa.

NDM spoke to Dr Katie Ewer, a Senior Immunologist involved in this trial, about the need for an Ebola vaccine and what the next steps are.

A new way of administering TB vaccines

A new way of administering TB vaccines

Posted 24/03/2015

Last year to mark World Tuberculosis Day NDM spoke to Professor Helen McShane to find out more about her research developing an improved TB vaccine. NDM spoke to her again to find out if there have been any developments in the last year.

University announces collaborative research projects with Pfizer

University announces collaborative research projects with Pfizer

Posted 02/03/2015

The University of Oxford is delighted to announce that the first collaborative research projects to be agreed by the University under the Pfizer Rare Disease Consortium have been signed.

MHRA supports innovative vaccine development at the University of Oxford

MHRA supports innovative vaccine development at the University of Oxford

Posted 04/03/2015

The University of Oxford and its Clinical BioManufacturing Facility have approached MHRA in order to receive feedback, guidance and support in the development and manufacture of a candidate vaccine for treatment of malaria that has seen them explore an innovative approach to viral vectors using a chimpanzee virus.

If you have news or events that you would like to be added to this website, please email us details. If possible, please include a picture and links to further information.